Pure Global AI
ANVISA registration 80146502411Valid until Jun 16, 2035

HERPES VIRUS (HHV 4) - EPSTEIN-BARR VIRUS (EBV)

ANVISA Registration Number: 80146502411ABBOTT LABORATORIOS DO BRASIL LTDAABBOTT MOLECULAR INCRisk Class IV
Verified
Device names
Technical name
HERPES VIRUS (HHV 4) - EPSTEIN-BARR VIRUS (EBV)
View exact technical-name matches →
PT: HERPES VÍRUS (HHV 4) - VÍRUS EPSTEIN-BARR (EBV)
Commercial name
Familia Alinity m EBV
View exact commercial-name matches →
Risk class
Class IV
Registration details
Registration Number
80146502411
Process Number
25351439114202472
CNPJ
56998701000116
Company information
Registration Holder
ABBOTT LABORATORIOS DO BRASIL LTDA
Manufacturer
ABBOTT MOLECULAR INC
Manufacturing Country
United States
PT: ESTADOS UNIDOS DA AMÉRICA
Dates and status
Publication Date
Jun 16, 2025
Validity
16/06/2035
Last Updated
08/18/2026 19:00:00
About this record

Access comprehensive regulatory information for HERPES VIRUS (HHV 4) - EPSTEIN-BARR VIRUS (EBV) in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 80146502411 and manufactured by ABBOTT MOLECULAR INC. The registration is held by ABBOTT LABORATORIOS DO BRASIL LTDA with validity until Jun 16, 2035.

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.